Next‐generation sequencing (NGS) studies have identified recurrent somatic mutations in AITL, and demonstrated common mutations in epigenetic pathway genes such as TET2 and DNMT3A in hematopoietic stem cells and AITL cells [15]. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.